Lifetime and 12-month prevalence estimates for mental disorders in northeastern Germany: findings from the Study of Health in Pomerania.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 16 02 2018
accepted: 31 05 2018
pubmed: 28 6 2018
medline: 27 8 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

Few epidemiological studies presented 12-month and lifetime prevalence estimates for DSM-IV mental disorders in the adult general population by sex and age up to very old age. From 2007 to 2010, DSM-IV mental disorders were assessed with the DIA-X/M-CIDI among N = 2400 participants (aged 29-89 years) from the Study of Health in Pomerania, an epidemiological study based on a two-stage stratified cluster sample randomly drawn from the adult general population in northeastern Germany. 36.3% of the sample was affected by any 12-month and 54.8% by any lifetime mental disorder. The most frequent diagnostic groups were anxiety (12-month: 14.8%, lifetime: 23.4%), substance use (12-month: 14.5%, lifetime: 25.0%), somatoform (12-month: 12.9%, lifetime: 20.4%) and depressive (12-month: 7.3%, lifetime: 18.6%) disorders. Except for substance use (higher prevalence in men) and bipolar disorders (comparable prevalence in men and women), higher 12-month and lifetime prevalence estimates were found in women vs. men. Moreover, lower 12-month and lifetime prevalence estimates were found in older (aged 60-74 or 75-89 years) vs. younger (aged 29-44 or 45-59 years) age groups. 22.6% (men: 21.1%, women: 23.9%) of those affected by any 12-month disorder met criteria for two and 13.6% (men: 9.6%, women: 16.9%) for three or more 12-month diagnoses. Similarly, 26.4% (men: 25.7%, women: 26.9%) of those affected by any lifetime disorder met criteria for two and 22.7% (men: 19.6%, women: 25.2%) for three or more lifetime diagnoses. Our findings demonstrate the frequency of mental disorders in northeastern Germany and emphasize the need for continued prevention and intervention efforts.

Identifiants

pubmed: 29948253
doi: 10.1007/s00406-018-0911-5
pii: 10.1007/s00406-018-0911-5
doi:

Types de publication

Journal Article

Langues

eng

Pagination

341-350

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ9603
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ0103
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ0403
Organisme : Deutsche Forschungsgemeinschaft
ID : GR1912/5-1

Références

Psychol Med. 1999 Jul;29(4):787-91
pubmed: 10473305
Psychol Med. 2000 Jan;30(1):11-22
pubmed: 10722172
Nervenarzt. 2000 Jul;71(7):535-42
pubmed: 10989807
Eur Arch Psychiatry Clin Neurosci. 2000;250(5):262-8
pubmed: 11097170
Psychol Med. 2004 May;34(4):597-611
pubmed: 15099415
Acta Psychiatr Scand Suppl. 2004;(420):21-7
pubmed: 15128384
Mol Psychiatry. 2005 Feb;10(2):220-4
pubmed: 15263905
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Psychol Med. 2008 Nov;38(11):1659-69
pubmed: 18485262
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Aust N Z J Psychiatry. 2009 Jul;43(7):594-605
pubmed: 19530016
Psychol Med. 2010 Feb;40(2):225-37
pubmed: 19531277
Psychol Med. 2010 Jun;40(6):899-909
pubmed: 19719899
Depress Anxiety. 2010 Apr;27(4):351-64
pubmed: 20037917
Int J Epidemiol. 2011 Apr;40(2):294-307
pubmed: 20167617
Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):203-13
pubmed: 21197531
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79
pubmed: 21924589
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
Psychiatr Prax. 2013 May;40(4):192-9
pubmed: 23564355
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Int J Methods Psychiatr Res. 2014 Sep;23(3):304-19
pubmed: 24729411
Int J Methods Psychiatr Res. 2015 Jun;24(2):116-29
pubmed: 25308743
Curr Psychiatry Rep. 2015 Feb;17(2):7
pubmed: 25617039
Soc Psychiatry Psychiatr Epidemiol. 2015 Jun;50(6):851-66
pubmed: 25982479
Eur Psychiatry. 2015 Sep;30(6):793-800
pubmed: 26169476
JAMA Psychiatry. 2015 Sep;72(9):892-9
pubmed: 26176785
Int J Methods Psychiatr Res. 2015 Dec;24(4):305-13
pubmed: 26184561
Br J Psychiatry. 2017 Feb;210(2):125-131
pubmed: 27609811
J Psychiatr Res. 1994 Mar-Apr;28(2):147-64
pubmed: 7932277
Eur Arch Psychiatry Clin Neurosci. 1995;245(6):272-87
pubmed: 8527464
Eur Arch Psychiatry Clin Neurosci. 1997;247(2):87-92
pubmed: 9177954
Soc Psychiatry Psychiatr Epidemiol. 1998 Nov;33(11):568-78
pubmed: 9803825

Auteurs

E Asselmann (E)

Behavioral Epidemiology, Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Chemnitzer Str. 46, 01187, Dresden, Germany. eva.asselmann@tu-dresden.de.
Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany. eva.asselmann@tu-dresden.de.

K Beesdo-Baum (K)

Behavioral Epidemiology, Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Chemnitzer Str. 46, 01187, Dresden, Germany.

A Hamm (A)

Department of Physiological and Clinical Psychology, University of Greifswald, Greifswald, Germany.

C O Schmidt (CO)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

J Hertel (J)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

H J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

C A Pané-Farré (CA)

Department of Physiological and Clinical Psychology, University of Greifswald, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH